Johnson Matthey PLC (LON:JMAT - Get Free Report) was up 30.5% on Thursday . The stock traded as high as GBX 1,888 ($25.62) and last traded at GBX 1,812 ($24.59). Approximately 4,684,272 shares changed hands during mid-day trading, an increase of 70% from the average daily volume of 2,756,710 shares. The stock had previously closed at GBX 1,389 ($18.85).
Johnson Matthey Stock Performance
The business has a 50 day moving average of GBX 1,313.40 and a 200-day moving average of GBX 1,377.22. The company has a market capitalization of £2.85 billion, a P/E ratio of 28.96, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The company has a debt-to-equity ratio of 62.73, a quick ratio of 0.76 and a current ratio of 1.45.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) earnings per share (EPS) for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. On average, sell-side analysts predict that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
The business also recently announced a dividend, which was paid on Wednesday, April 16th. Shareholders of record on Thursday, April 10th were given a dividend of GBX 32 ($0.43) per share. The ex-dividend date of this dividend was Thursday, April 10th. This is a positive change from Johnson Matthey's previous dividend of $22.00. This represents a yield of 1.88%. Johnson Matthey's payout ratio is presently 130.84%.
Insiders Place Their Bets
In other news, insider Liam Condon bought 30 shares of the business's stock in a transaction on Wednesday, April 16th. The stock was acquired at an average price of GBX 1,200 ($16.28) per share, with a total value of £360 ($488.47). Insiders purchased a total of 75 shares of company stock valued at $99,927 in the last quarter. Corporate insiders own 0.61% of the company's stock.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Featured Articles
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
